Evidence map›Paper›PMID 41465833›Full record

ArticleLife (Basel, Switzerland)2025

Ki-67 and Tumor Size in Small Bowel Tumors: Findings from an Exploratory Immunohistochemical Analysis.

Laurențiu Augustus Barbu, Liliana Cercelaru, Valeriu Șurlin, Stelian-Stefaniță Mogoantă, Tiberiu Stefăniță Țenea Cojan, Daniela Marinescu, Nicolae-Dragoș Mărgăritescu, Liviu Vasile

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Immunohistochemical predictors of local recurrence in breast carcinoma: development and sensitivity validation of an IHC-based risk score.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Article
  6. Ileal neuroendocrine tumors: clinicopathological features and associations with systemic inflammatory and nutritional markers.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Article
  7. Primary cutaneous extraskeletal Ewing sarcoma of the plantar region: clinicopathological features and review of the literature.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laurențiu Augustus BarbuDepartment of Surgery, Railway Clinical Hospital Craiova, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.ORCID 0009-0008-5822-8805
Liliana CercelaruDepartment of Embryology and Anatomy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.ORCID 0000-0002-8232-3457
Valeriu ȘurlinDepartment of Surgery, Emergency County Hospital, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.ORCID 0000-0003-2648-5408
Stelian-Stefaniță MogoantăDepartment of Surgery, Emergency County Hospital, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Tiberiu Stefăniță Țenea CojanDepartment of Surgery, Railway Clinical Hospital Craiova, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Daniela MarinescuDepartment of Surgery, Emergency County Hospital, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Nicolae-Dragoș MărgăritescuDepartment of Surgery, Emergency County Hospital, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Liviu VasileDepartment of Surgery, Emergency County Hospital, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.ORCID 0000-0002-7018-5675

Funding

University of Medicine and Pharmacy of Craiova N/A
6 · The paper itself

Abstract

backgroundSmall bowel tumors are rare and biologically diverse, and prognostic assessment remains difficult, particularly regarding proliferative markers such as Ki-67 and tumor size.

objectiveTo evaluate the clinicopathological and immunohistochemical characteristics of small bowel tumors and explore factors associated with malignancy.

methodsA retrospective analysis of 61 surgically treated primary small bowel tumors (2020-2024) was performed using WHO 2019/2022 and AJCC 8th criteria. Immunohistochemistry included CD117, DOG1, CD34, SMA, and Ki-67.

resultsAdenocarcinomas were most frequent (52.5%), followed by GISTs (26.2%) and NETs (9.8%). CD117 and DOG1 were expressed in 93.8% of GISTs, confirming high diagnostic specificity. The median Ki-67 index was 8%, significantly higher in non-GIST tumors (

conclusionsTumor size and Ki-67 were associated with malignancy in this exploratory multivariable analysis, but these findings should be interpreted with caution due to limited follow-up and sample imbalance. Combined with CD117/DOG1 profiling, they enhance diagnostic accuracy and may inform diagnostic assessment; however, prognostic implications require outcome-based studies.

Indexed as

CD117CD34DOG1gastrointestinal stromal tumor (GIST)immunohistochemistryKi-67small bowel tumorstumor size

Identifiers

PMID41465833
PMCPMC12734588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.